SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-18-004028
Filing Date
2018-05-04
Accepted
2018-05-04 16:06:28
Documents
111
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q irwd-20180331x10q.htm 10-Q 2397136
2 EX-31.1 irwd-20180331ex3114f234a.htm EX-31.1 18539
3 EX-31.2 irwd-20180331ex3129b5dd8.htm EX-31.2 18509
4 EX-32.1 irwd-20180331ex321272584.htm EX-32.1 8474
5 EX-32.2 irwd-20180331ex3225ce625.htm EX-32.2 8608
  Complete submission text file 0001558370-18-004028.txt   10659967

Data Files

Seq Description Document Type Size
6 EX-101.INS irwd-20180331.xml EX-101.INS 2336800
7 EX-101.SCH irwd-20180331.xsd EX-101.SCH 84510
8 EX-101.CAL irwd-20180331_cal.xml EX-101.CAL 79680
9 EX-101.DEF irwd-20180331_def.xml EX-101.DEF 457103
10 EX-101.LAB irwd-20180331_lab.xml EX-101.LAB 675805
11 EX-101.PRE irwd-20180331_pre.xml EX-101.PRE 694000
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 617-621-7722
IRONWOOD PHARMACEUTICALS INC (Filer) CIK: 0001446847 (see all company filings)

IRS No.: 043404176 | State of Incorp.: DE
Type: 10-Q | Act: 34 | File No.: 001-34620 | Film No.: 18807925
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences